Literature DB >> 22373095

3D6 and 4B3: Recombinant expression of two anti-gp41 antibodies as dimeric and secretory IgA.

David Reinhart1, Robert Weik2, Renate Kunert2.   

Abstract

Entities:  

Year:  2011        PMID： 22373095      PMCID： PMC3285001          DOI： 10.1186/1753-6561-5-S8-P56

Source DB:  PubMed          Journal:  BMC Proc        ISSN： 1753-6561


× No keyword cloud information.
  5 in total

Review 1.  The IgA system: a comparison of structure and function in different species.

Authors:  Veerle Snoeck; Iain R Peters; Eric Cox
Journal:  Vet Res       Date:  2006-02-23       Impact factor: 3.683

2.  Solution structure of human secretory component and implications for biological function.

Authors:  Alexandra Bonner; Clémentine Perrier; Blaise Corthésy; Stephen J Perkins
Journal:  J Biol Chem       Date:  2007-04-11       Impact factor: 5.157

3.  Secretory component delays the conversion of secretory IgA into antigen-binding competent F(ab')2: a possible implication for mucosal defense.

Authors:  P Crottet; B Corthésy
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

4.  Molecular characterization of five neutralizing anti-HIV type 1 antibodies: identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5.

Authors:  R Kunert; F Rüker; H Katinger
Journal:  AIDS Res Hum Retroviruses       Date:  1998-09-01       Impact factor: 2.205

5.  Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization.

Authors:  A Buchacher; R Predl; K Strutzenberger; W Steinfellner; A Trkola; M Purtscher; G Gruber; C Tauer; F Steindl; A Jungbauer
Journal:  AIDS Res Hum Retroviruses       Date:  1994-04       Impact factor: 2.205
  5 in total
  1 in total

1.  Development of genetic markers in Eucalyptus species by target enrichment and exome sequencing.

Authors:  Modhumita Ghosh Dasgupta; Veeramuthu Dharanishanthi; Ishangi Agarwal; Konstantin V Krutovsky
Journal:  PLoS One       Date:  2015-01-20       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.